Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said on Monday.The injectable vaccine, called RTS,S or Mosquirix, was developed by British drugmaker GlaxoSmithKline to protect children from the most deadly form of malaria in Africa. In clinical trials it proved only partially effective, and it needs to be given in a four-dose schedule, but is the first regulator-approved vaccine against the mosquito-borne disease. Read more
Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018
Highly skilled in tracking details, communicating deadlines, and following up with internal and external stakeholders to ensure on time completion within budget. Ability and interest in learning and incorporating new technology.
Latest from Heri Marco
- Funding sources for Startups & Development Projects in Africa
- Data insights from the Top 250 Fintech ventures in 2020 according to CB Insights
- Highlights of the Future Of Travel & Tourism In The Wake Of Covid-19.
- Adaptation Fund Climate Innovation Accelerator – UNEP-CTCN
- Applications open for 7th Tony Elumelu Entrepreneurship Programme